PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Pentraxin-3 modulates lipopolysaccharide-induced inflammatory response and attenuates liver injury.

Mixed / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 28422322 ↗2017Reported benefit

Pentraxin-3 modulates lipopolysaccharide-induced inflammatory response and attenuates liver injury.

MixedEndotoxin/LPSC57BL/6Malen = Mouse group sizes not stated; human cohort 54 patients with…Intraperitoneal5 mg/kg body weight2 hours before intravenous lipopolysaccharide

Model: Chronic liver injury with carbon tetrachloride 0.5 mL/kg intraperitoneally twice weekly for 2 weeks, followed by lipopolysaccharide 2.5 mg/kg intravenously to produce acute-on-chronic injury

Recombinant PTX3 attenuated lipopolysaccharide-induced liver injury, inflammation and cell recruitment, and PTX3 expression was raised in patients with alcoholic hepatitis in proportion to disease severity.

Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.